Matching slides 303,780
Current window 200,281-200,310
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

200,281-200,310 of 303,780

filter-aware
37
BioAtla | Investor Presentation Deck | 37 slidesBioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations 1 hit
01
Slide 1
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
02
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
03
Standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
04
Standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
05
Standard pharmaceutical safety disclosure slide.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
06
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
07
The slide uses a semi-circular layout to represent the company's strategic pillars.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
08
The slide uses a structured grid layout to categorize key performance indicators.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
09
The slide uses a list-based timeline/milestone format to highlight growth across five key areas.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The slide highlights organizational scale and diversity metrics as of Dec 31, 2021.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
11
The slide uses a structured layout to present four pillars of corporate social responsibility.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
12
The slide categorizes partnerships into clinical stage and pre-clinical programs, detailing the nature of the collaboration (e.g., cost/profit share, royalties).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
13
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The diagram uses a hexagonal grid to represent different technology platforms and their development status/origin.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
17
Includes product image and key performance metrics.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
19
The slide uses a two-column layout to contrast the 'why' (medical need) with the 'how' (technologies).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
20
The chart uses a horizontal bar representation to indicate the clinical stage of each program.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a Gantt-style visualization to show clinical trial phases for various drug candidates.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
24
The slide uses a matrix structure to compare different drug development programs.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
25
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
26
The slide uses a grouped table structure to categorize milestones by therapeutic area (COVID-19, Infectious Disease, Oncology, Data Updates).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
27
The slide uses a column-based layout to categorize strategic initiatives, with a footer highlighting foundational enablers.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
01
Slide 1
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
02
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
04
Standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
05
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit